(Q83334262)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697447%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

title

Prognostic significance of neuroendocrine expression in lymph node-positive prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697447%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697447%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Siamak Daneshmand

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697447%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

author name string

Sonali Rodrigo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697447%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Jie Cai

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697447%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Tanya B Dorff

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697447%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Susan Groshen

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697447%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Donald G Skinner

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697447%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Gary Lieskovsky

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697447%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

Jacek Pinski

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697447%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

publication date

12 May 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697447%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697447%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

volume

67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697447%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697447%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

page(s)

1247-1252

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697447%20AND%20SRC:MED&resulttype=core&format=json

Neuroendocrine differentiation in prostatic carcinoma

21 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.009

Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.009

Neuroendocrine differentiation in prostate cancer: implications for new treatment modalities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.009

Neuroendocrine cell differentiation in the CWR22 human prostate cancer xenograft: association with tumor cell proliferation prior to recurrence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.009

Neuroendocrine differentiation in prostatic malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.009

The course of neuroendocrine differentiation in prostatic carcinomas. An immunohistochemical study testing chromogranin A as an "endocrine marker"

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.009

Peptide-hormone- and serotonin-immunoreactive tumour cells in carcinoma of the prostate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.009

Neuroendocrine cells in benign prostatic hyperplasia and prostatic carcinoma: effect of hormonal treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.009

The Prognostic Value of Neuroendocrine Differentiation in Adenocarcinoma of the Prostate in Relation to Progression of Disease After Endocrine Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.009

Neuroendocrine differentiation in prostatic carcinoma during hormonal treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.009

Interleukin-6 induces G1 arrest through induction of p27(Kip1), a cyclin-dependent kinase inhibitor, and neuron-like morphology in LNCaP prostate tumor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.009

STAT3 mediates IL-6-induced neuroendocrine differentiation in prostate cancer cells .

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.009

Interleukin-6- and cyclic AMP-mediated signaling potentiates neuroendocrine differentiation of LNCaP prostate tumor cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.009

Activated 3',5'-cyclic AMP-dependent protein kinase is sufficient to induce neuroendocrine-like differentiation of the LNCaP prostate tumor cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.009

Prostatic carcinoma: histological and immunohistological factors affecting prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.009

Neuroendocrine differentiation in prostate cancer: enhanced prediction of progression after radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.009

Neuroendocrine differentiation in prostatic adenocarcinoma and its relationship to tumor progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.009

The prognostic influence of neuroendocrine cells in prostate cancer: Results of a long-term follow-up study with patients treated by radical prostatectomy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.009

Are neuroendocrine cells of practical value as an independent prognostic parameter in prostate cancer?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.009

Chromogranin A and B and secretogranin II in prostatic adenocarcinomas: neuroendocrine expression in patients untreated and treated with androgen deprivation therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.009

Prostate cancer and neuroendocrine differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.009

Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.009

Inhibitory effect of IL-6-induced neuroendocrine cells on prostate cancer cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.009

Interleukin-6 inhibits the growth of prostate cancer xenografts in mice by the process of neuroendocrine differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.009

Characterization of neuroendocrine differentiation in human benign prostate and prostatic adenocarcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2005.12.009

10.1016/J.UROLOGY.2005.12.009

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16697447%20AND%20SRC:MED&resulttype=core&format=json

21 January 2020

1 reference